A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

Summary

This study is looking at how Mim8 works compared to other medicines in children with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be used for prevention of bleeds. Mim8 will be injected with a thin needle into the skin. The study will last for about 54-98 weeks, from screening to follow-up visit, In case the participant experiences bleeds, these can be treated with additional haemostatic medicine as agreed with the study doctor.

Timeline

Start

2022-04-04

Primary completion

2024-11-13

Completion

2024-11-13

Drugs

Indications